Acute Graft-Versus-Host Disease After Humanized Anti-CD19-CAR T Therapy in Relapsed B-ALL Patients After Allogeneic Hematopoietic Stem Cell Transplant

We studied the acute graft-versus-host disease (GVHD) after humanized anti-CD19-CAR T therapy in relapsed B-acute lymphoblastic leukemia (ALL) patients after allogeneic hematopoietic stem cell transplant (allo-HSCT). Fifteen B-ALL patients were enrolled in our study. Thirteen patients (86.67%) achie...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Pengjiang, Liu, Meijing, Lyu, Cuicui, Lu, Wenyi, Cui, Rui, Wang, Jia, Li, Qing, Mou, Nan, Deng, Qi, Yang, Donglin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7551306/
https://www.ncbi.nlm.nih.gov/pubmed/33117709
http://dx.doi.org/10.3389/fonc.2020.573822

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7551306/
https://www.ncbi.nlm.nih.gov/pubmed/33117709
http://dx.doi.org/10.3389/fonc.2020.573822

Ejemplares similares